<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00874133</url>
  </required_header>
  <id_info>
    <org_study_id>004589</org_study_id>
    <nct_id>NCT00874133</nct_id>
  </id_info>
  <brief_title>The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis</brief_title>
  <official_title>The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes affects 5.8% of the adult population in Israel (1). Gastroparesis is a syndrome&#xD;
      characterized by delayed gastric emptying in the absence of mechanical obstruction of the&#xD;
      stomach.Treatment with acupuncture has been described as effective in improvement of symptoms&#xD;
      in patients with gastroparesis in a number of patient series. However, this treatment&#xD;
      approach has not been tested by means of a controlled randomized clinical study, and neither&#xD;
      has the connection between improvement of symptoms and the anatomical-physiological effect of&#xD;
      the treatment, if ever, assessed.This study will test the efficacy of motilium (20 mg thrice&#xD;
      daily) as compared to acupuncture treatment on the following subjective and objective&#xD;
      parameters of 30 patients with diabetic gastroparesis and impaired glucose control:&#xD;
&#xD;
        1. To compare the degree of GCSI scores improvement before and after treatment with&#xD;
           motilium or acupuncture using a validated questionnaire.&#xD;
&#xD;
        2. To determine the effect of treatment with motilium or acupuncture on gastric emptying&#xD;
           rate.&#xD;
&#xD;
        3. To determine the effect of treatment with motilium or acupuncture on glycemic control.&#xD;
&#xD;
        4. To compare the quality of life before and after treatment with motilium or acupuncture&#xD;
           using the Short Form-36 (SF-36).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, comparative, pilot study, which will compare two treatments:&#xD;
      acupuncture treatment vs. treatment with motilium in 30 diabetic patients with impaired&#xD;
      glucose control and gastroparesis.&#xD;
&#xD;
      All patients who meet inclusion criteria will undergo gastric scintigraphy and upper&#xD;
      endoscopy to assess the presence of gastroparesis and to rule out gastric outlet obstruction.&#xD;
      At baseline, all enrolled patients will fill out the Gastroparesis Cardinal Symptom Index&#xD;
      (GCSI), the Quality of life questionnaire (SF-36). Subsequently, patients will be randomized&#xD;
      to 20 mg motilium thrice daily and after 1 month wash-out period to acupuncture treatment,&#xD;
      each treatment will last 12 weeks.&#xD;
&#xD;
      After treatment, patients will undergo a second gastric scintigraphy and will complete the&#xD;
      GCSI and the SF-36.&#xD;
&#xD;
      Fasting blood glucose concentrations and HbA1c levels will be determined at the beginning and&#xD;
      at the end of the study and at 6 months later as well.&#xD;
&#xD;
      End Points:&#xD;
&#xD;
      Primary: Level of improvement of gastric emptying rate, and improvement in blood glucose&#xD;
      levels at the end of treatment, in comparison with tests before treatment.&#xD;
&#xD;
      Secondary: Level of improvement in scores of severity of gastroparesis related symptoms, with&#xD;
      quality of life indicators, in comparison with tests before treatment; also, the number of&#xD;
      visits to family doctors/diabetic clinics/emergency rooms, as well as use of the medications&#xD;
      resulting from diabetic complications will be investigated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Completed due to low number of eligible patients&#xD;
  </why_stopped>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of improvement of gastric emptying rate</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in blood glucose levels</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Diabetic Gastroparesis</condition>
  <arm_group>
    <arm_group_label>Motillium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 mg motilium thrice daily for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acupuncture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acupuncture treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Acupuncture treatment for 12 weeks.</description>
    <arm_group_label>Acupuncture</arm_group_label>
    <other_name>Domperidone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Motilium</intervention_name>
    <description>20 mg motilium thrice daily</description>
    <arm_group_label>Motillium</arm_group_label>
    <other_name>Domperidone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 18-80,&#xD;
&#xD;
          -  Diabetic patients of over 10 years duration with impaired glucose control, after at&#xD;
             least 6 months of accepted treatment in a Diabetes Clinic by the study staff before&#xD;
             inclusion in the study, who exhibit symptoms which could signify the possibility of&#xD;
             diabetic gastroparesis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known hyperprolactinemia, systemic or localized neurological disturbances (myopathy,&#xD;
             multiple sclerosis, Parkinson's disease, myelopathy), with the exception of diabetic&#xD;
             neuropathy, past stomach or esophagus surgery, pregnancy, inability to sign Informed&#xD;
             Consent, fear of acupuncture, limb amputation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ram Dickman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RMC</affiliation>
  </overall_official>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>March 25, 2009</study_first_submitted>
  <study_first_submitted_qc>April 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2009</study_first_posted>
  <last_update_submitted>December 5, 2013</last_update_submitted>
  <last_update_submitted_qc>December 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rabin Medical Center</investigator_affiliation>
    <investigator_full_name>dickman ram</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Domperidone</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>September 19, 2017</submitted>
    <returned>October 17, 2017</returned>
    <submitted>September 5, 2018</submitted>
    <returned>October 2, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

